TR200102236T2 - Kolesterol-düşürme amilinin kullanımı. - Google Patents

Kolesterol-düşürme amilinin kullanımı.

Info

Publication number: TR200102236T2
Authority: TR; Turkey
Prior art keywords: cholesterol; lowering agent; dosages; bulus; dihydroxyhept
Prior art date: 1999-02-06

Application number

TR2001/02236T

Other languages

English (en)

Turkish (tr)

Inventor

Raza Ali

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-06

Filing date

2000-02-01

Publication date

2001-12-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315084&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200102236(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-02-06 Priority claimed from GBGB9902590.0A external-priority patent/GB9902590D0/en

1999-09-08 Priority claimed from GBGB9921062.7A external-priority patent/GB9921062D0/en

2000-02-01 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2001-12-21 Publication of TR200102236T2 publication Critical patent/TR200102236T2/xx

Links

239000003529 anticholesteremic agent Substances 0.000 title 1
229940127226 anticholesterol agent Drugs 0.000 title 1
150000002632 lipids Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

TR2001/02236T 1999-02-06 2000-02-01 Kolesterol-düşürme amilinin kullanımı. TR200102236T2 (tr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9902590.0A GB9902590D0 (en)	1999-02-06	1999-02-06	Use of cholesterol-lowering agent
GBGB9921062.7A GB9921062D0 (en)	1999-09-08	1999-09-08	Use of cholestrol-lowering agent

Publications (1)

Publication Number	Publication Date
TR200102236T2 true TR200102236T2 (tr)	2001-12-21

Family

ID=26315084

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR2001/02236T TR200102236T2 (tr)	1999-02-06	2000-02-01	Kolesterol-düşürme amilinin kullanımı.

Country Status (22)

Country	Link
EP (1)	EP1150679A1 (is)
JP (2)	JP2002536333A (is)
KR (1)	KR100699287B1 (is)
CN (1)	CN1347320A (is)
AR (1)	AR022462A1 (is)
AU (1)	AU769897B2 (is)
BR (1)	BR0007991A (is)
CA (1)	CA2358641A1 (is)
CZ (1)	CZ20012631A3 (is)
EE (1)	EE04659B1 (is)
HK (1)	HK1040924A1 (is)
HU (1)	HUP0105019A3 (is)
ID (1)	ID30131A (is)
IL (1)	IL144662A0 (is)
IS (1)	IS5996A (is)
MY (1)	MY136382A (is)
NO (1)	NO319827B1 (is)
NZ (1)	NZ512681A (is)
PL (1)	PL349137A1 (is)
SK (1)	SK11112001A3 (is)
TR (1)	TR200102236T2 (is)
WO (1)	WO2000045819A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0001621D0 (en)	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
GB0003305D0 (en)	2000-02-15	2000-04-05	Zeneca Ltd	Pyrimidine derivatives
SE0103509D0 (sv) *	2001-10-19	2001-10-19	Astrazeneca Ab	Rosuvastatin in pre demented states
GB0322552D0 (en)	2003-09-26	2003-10-29	Astrazeneca Uk Ltd	Therapeutic treatment
WO2007142581A1 (en) *	2006-06-07	2007-12-13	Astrazeneca Ab	Combination product for the treatment or prevention of dyslipidaemia
CA2689525A1 (en) *	2007-06-20	2008-12-24	Merck Sharp & Dohme Corp.	Cetp inhibitors derived from benzoxazole arylamides
CA2689575A1 (en)	2007-06-20	2008-12-24	Merck Sharp & Dohme Corp.	Cetp inhibitors derived from benzoxazole arylamides
JP2010530417A (ja) *	2007-06-20	2010-09-09	メルク・シャープ・エンド・ドーム・コーポレイション	ベンゾオキサゾールアリールアミドから誘導されたｃｅｔｐ阻害剤
EP2216095A1 (en) *	2009-01-27	2010-08-11	Koninklijke Philips Electronics N.V.	Microfluidic device for full blood count

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5260446A (en) *	1989-12-22	1993-11-09	Basf Aktiengesellschaft	Aminothiazoles
JP2648897B2 (ja) *	1991-07-01	1997-09-03	塩野義製薬株式会社	ピリミジン誘導体

2000
- 2000-01-31 AR ARP000100408A patent/AR022462A1/es unknown
- 2000-02-01 AU AU23051/00A patent/AU769897B2/en not_active Revoked
- 2000-02-01 IL IL14466200A patent/IL144662A0/xx unknown
- 2000-02-01 CZ CZ20012631A patent/CZ20012631A3/cs unknown
- 2000-02-01 NZ NZ512681A patent/NZ512681A/en not_active IP Right Cessation
- 2000-02-01 EP EP00901748A patent/EP1150679A1/en not_active Withdrawn
- 2000-02-01 KR KR1020017009822A patent/KR100699287B1/ko not_active Ceased
- 2000-02-01 HU HU0105019A patent/HUP0105019A3/hu unknown
- 2000-02-01 HK HK02102713.0A patent/HK1040924A1/zh unknown
- 2000-02-01 JP JP2000596939A patent/JP2002536333A/ja not_active Withdrawn
- 2000-02-01 EE EEP200100404A patent/EE04659B1/xx not_active IP Right Cessation
- 2000-02-01 PL PL00349137A patent/PL349137A1/xx not_active Application Discontinuation
- 2000-02-01 TR TR2001/02236T patent/TR200102236T2/xx unknown
- 2000-02-01 BR BR0007991-0A patent/BR0007991A/pt not_active Application Discontinuation
- 2000-02-01 ID IDW00200101666A patent/ID30131A/id unknown
- 2000-02-01 WO PCT/GB2000/000285 patent/WO2000045819A1/en not_active Ceased
- 2000-02-01 CN CN00803519A patent/CN1347320A/zh active Pending
- 2000-02-01 SK SK1111-2001A patent/SK11112001A3/sk not_active Application Discontinuation
- 2000-02-01 CA CA002358641A patent/CA2358641A1/en not_active Abandoned
- 2000-02-04 MY MYPI20000415A patent/MY136382A/en unknown
2001
- 2001-07-10 IS IS5996A patent/IS5996A/is unknown
- 2001-08-03 NO NO20013810A patent/NO319827B1/no active IP Right Review Request
2011
- 2011-02-22 JP JP2011035406A patent/JP2011137023A/ja active Pending

Also Published As

Publication number	Publication date
CZ20012631A3 (cs)	2001-10-17
AU769897B2 (en)	2004-02-05
MY136382A (en)	2008-09-30
NO20013810L (no)	2001-10-03
HUP0105019A3 (en)	2003-02-28
JP2011137023A (ja)	2011-07-14
JP2002536333A (ja)	2002-10-29
NO20013810D0 (no)	2001-08-03
PL349137A1 (en)	2002-07-01
EE200100404A (et)	2002-10-15
BR0007991A (pt)	2001-11-06
EE04659B1 (et)	2006-08-15
KR20010089631A (ko)	2001-10-06
EP1150679A1 (en)	2001-11-07
NZ512681A (en)	2003-12-19
IL144662A0 (en)	2002-05-23
IS5996A (is)	2001-07-10
HUP0105019A2 (hu)	2002-05-29
KR100699287B1 (ko)	2007-03-26
ID30131A (id)	2001-11-08
NO319827B1 (no)	2005-09-19
AR022462A1 (es)	2002-09-04
CN1347320A (zh)	2002-05-01
CA2358641A1 (en)	2000-08-10
AU2305100A (en)	2000-08-25
WO2000045819A1 (en)	2000-08-10
SK11112001A3 (sk)	2002-02-05
HK1040924A1 (zh)	2002-06-28

Similar Documents

Publication	Publication Date	Title
RU2407532C9 (ru)	2011-12-20	Комбинации, предназначенные для лечения заболеваний, включающих пролиферацию клеток
CR10114A (es)	2008-08-21	Composiciones farmacéuticas que comprenden inhibidoras de la hmg coa reductasa (divisional del exp. 6687)
DE69812949D1 (de)	2003-05-08	Hydroxamsäurederivat und antitumormittel enthaltende pharmazeutische zusammensetzung mit verbesserter antitumor-aktivität und/oder verringerten nebenwirkungen
CY1109756T1 (el)	2014-09-10	Φαρμακευτικες συνθεσεις που περιεχουν κρυσταλλικα αλατα 7-[4-(4-φθοροφαινυλ)-6-ισοπροπυλ-2- [μεθυλ(μεθυλσουλφονυλ)αμινο] πυριμιδιν-5-υλ]-(3r,5s)-3,5-διυδροξυεπτ-6-ενοϊκου οξεος
BR0113331A (pt)	2004-02-25	Derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica
TR200103613T2 (tr)	2004-08-23	Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
BRPI0015567B8 (pt)	2021-05-25	composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
EA200400777A1 (ru)	2004-12-30	Фармацевтические композиции соединения платины
TR199801530T2 (xx)	1998-11-23	VEGF �nhibit�rleri olarak kinazolin t�revleri.
TR200100894T2 (tr)	2001-10-22	Aril ikameli propanolamin türevleri, imalat yöntemleri, ilaç maddeleri, kullanımları.
HUP0301380A2 (hu)	2003-10-28	Roszuvasztatin (ZD-4522) felhasználása heterozigóta örökletes hiperkoleszterolémia kezelésére alkalmas gyógyszerkészítmény előállítására
JP2006508953A5 (is)	2006-12-21
JPH11193282A5 (is)	2005-09-02
NO20034863L (no)	2003-12-30	Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
TR199900336T2 (xx)	1999-04-21	EAA antagonistleri olarak tetrahidrokinolin t�revleri.
BRPI0008228B8 (pt)	2021-05-25	composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
DE60313359D1 (de)	2007-05-31	Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
HU229443B1 (en)	2013-12-30	Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
TR200103153T2 (tr)	2002-04-22	Yeni bileşimler
TR200101633T2 (tr)	2002-06-21	Farmasötik bileşim
EE200100104A (et)	2002-06-17	5-HT4 agonisti või antagonisti uus peroraalne ravimvorm
SE0300908D0 (sv)	2003-03-31	Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
CA2302568A1 (en)	1999-03-18	Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
SE0102440D0 (sv)	2001-07-05	New compound
HK1040924A1 (zh)	2002-06-28	降膽固醇劑的應用